<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03712189</url>
  </required_header>
  <id_info>
    <org_study_id>CHLA-18-00188</org_study_id>
    <nct_id>NCT03712189</nct_id>
  </id_info>
  <brief_title>LifeFlow Fluid Study- Non- Critical Pediatric Patients Having a Trans Abdominal Ultrasound</brief_title>
  <official_title>The Utility of LifeFlow Rapid Fluid Infuser in Critical and Non-critical Pediatric Patients: a Mixed-method Pilot Study Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>410 Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Atlanta Pediatric Device Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an unblinded, randomized control study examining two fluid delivery modalities for
      non-critical female patients with a planned transabdominal pelvic ultrasound requiring
      intravenous fluid boluses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects be identified during their clinical course in the ED and will be randomized to
      either the LifeFlow® fluid delivery or an IV fluid bolus through the Alaris® pump (standard
      of care). IV fluids will be provided until the subject notes the sensation of a full bladder,
      at which point, the standard of care clinical practice is to perform the ultrasound. The
      transabdominal pelvic ultrasound requires a full bladder for optimal visualization of the
      ovaries, adnexa, and uterus, and is the only alternative to a transvaginal pelvic ultrasound
      for virginal young women. All other clinical care is per standard of care. The only research
      component is the randomization and data collection.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2, 2018</start_date>
  <completion_date type="Actual">June 30, 2019</completion_date>
  <primary_completion_date type="Actual">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration- Ultrasound ordered to completed</measure>
    <time_frame>From ED (Emergency Department) arrival to discharge/admission, less than 12 hours</time_frame>
    <description>The primary outcome variable is the duration (minutes) of time from when the ultrasound was ordered to the completion time of the ultrasound.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total IV fluid (mL)</measure>
    <time_frame>From ED arrival to discharge/admission, less than 12 hours</time_frame>
    <description>Total IV fluid administered before ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration- Full bladder</measure>
    <time_frame>From ED arrival to discharge/admission, less than 12 hours</time_frame>
    <description>Fluid initiation and subjective sensation of full bladder</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration- Nursing</measure>
    <time_frame>From ED arrival to discharge/admission, less than 12 hours</time_frame>
    <description>Nursing time required to administer the fluids</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Dehydration in Children</condition>
  <condition>Dehydration</condition>
  <arm_group>
    <arm_group_label>Alaris Pump</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants will receive IV fluids delivered by the Alaris IV Pump (standard of care) until their bladder is full.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LifeFlow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive IV fluids delivered by the LifeFlow Fluid Device until their bladder is full.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LifeFlow</intervention_name>
    <description>The LifeFlow® is a hand-operated rapid infuser designed to administer fluids to patients by a single user, for clinical situations in which a large volume or rapid infusion of fluid or colloid is required. The device delivers fluid in 10mL increments with each complete handle compression, which refills during release, automating a push-pull mechanism. The syringe then automatically refills with handle release.</description>
    <arm_group_label>LifeFlow</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients older than 1 month and less than 18 years

          -  Patients require IV crystalloid bolus fluids before a pelvic ultrasound

        Exclusion Criteria:

          -  Known cardiac insufficiency or significant cardiac surgery

          -  Hepatic insufficiency

          -  Renal insufficiency

          -  Any known fluid overload states (ascites, pulmonary edema)

          -  On any diuretic or antihypertensive therapy

          -  Known pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Todd P Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Los Angeles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ara Festekjian, MD</last_name>
    <role>Study Director</role>
    <affiliation>Children's Hospital Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kline M, Crispino L, Bhatnagar A, Panchal RA, Auerbach M. A Randomized Single-Blinded Simulation-Based Trial of a Novel Method for Fluid Administration to a Septic Infant. Pediatr Emerg Care. 2018 Aug 25. doi: 10.1097/PEC.0000000000001583. [Epub ahead of print]</citation>
    <PMID>30106868</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>October 11, 2018</study_first_submitted>
  <study_first_submitted_qc>October 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>July 23, 2019</last_update_submitted>
  <last_update_submitted_qc>July 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dehydration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/89/NCT03712189/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

